disease 1,721 words KG: ent-dise-2fb44e60
Contents

Beta-Propeller Protein-Associated Neurodegeneration (BPAN)

Disease Info
Impaired autophagic fluxAccumulation of aberrant early autophagic structures and failure to form mature autophagosomes
Defective mitophagyInability to clear damaged mitochondria, leading to mitochondrial dysfunction and oxidative stress
ER stressAccumulation of misfolded proteins due to impaired ER-phagy (selective autophagy of endoplasmic reticulum)
Iron dysregulationDisrupted ferritinophagy (autophagic degradation of ferritin) leading to abnormal intracellular iron accumulation
Global developmental delayMotor and language milestones are delayed, with most children achieving independent ambulation but with an abnormal gait
Intellectual disabilityRanges from mild to severe; most patients have moderate to severe cognitive impairment
Rett-like featuresStereotypic hand movements, bruxism, and sleep disturbances resembling Rett syndrome are common
Behavioral featuresHyperactivity, autistic traits, and disordered sleep
Disordered sleepDisrupted sleep architecture with poor sleep initiation and maintenance
ParkinsonismProgressive bradykinesia, rigidity, postural instability, and rest tremor. Initially levodopa-responsive, but response diminishes over time
DystoniaGeneralized or segmental dystonia, often severe, affecting limbs, trunk, and orofacial muscles
Cognitive declineProgressive dementia with prominent frontal-subcortical features, often leading to loss of previously acquired language and functional abilities
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Related Hypotheses (30)

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
CYP46A1 Overexpression Gene Therapy
Score: 0.92
SASP-Mediated Complement Cascade Amplification
Score: 0.91
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.91
Transcriptional Autophagy-Lysosome Coupling
Score: 0.88

Related Analyses (30)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40

See Also (15)

Metabolomic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
Adrenal Chromaffin Cells in Neurodegeneration
cell · Pages share 139 hypotheses
MDS 2026 — Fluid Biomarker Advances in Neurodegeneratio
event · Pages share 139 hypotheses
Blood-Based Biomarkers for Neurodegeneration
biomarker · Pages share 139 hypotheses
Neuroimaging Biomarkers for Neurodegeneration
biomarker · Pages share 139 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)